Find Funding Opportunities

Returning 743 results

Notice of New Budget Limitation for PAR-16-331 Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)

NOT
Tuesday, June 12, 2018
Friday, January 1, 2021
NOT-NS-18-071

Funding Opportunity Purpose

Notice New Budget Limitation PAR-16-331 Countermeasures Against Chemical Threats CounterACT): Optimization Therapeutic Lead Compounds U01) Notice Number: NOT-NS-18-071 Key Dates Release Date: June 12, 2018 Related Announcements PAR-16-331 Issued National Institute Neurological Disorders Stroke NINDS) National Eye Institute NEI) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) Purpose purpose this notice to amend award budget PAR-16-331 Countermeasures Against Chemical Threats CounterACT): Optimization Therapeutic Lead Compounds U01)." Section II. Award Information Currently Reads: Award Budget Application budgets not limited, need reflect actual needs the proposed project. most applications within scope this FOA, expected direct cost individual awards 300,000-$500,000 per year. applications not need request maximum budget the size duration the awards vary depending upon nature scope research programs. Modified Read: Award Budget Application Budget not exceed $500,000 in direct costs per year. applications not need request maximum budget the size duration the awards vary because nature scope research programs vary. other aspects this FOA remain same. Inquiries Please direct inquiries to: David A. Jett, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone:  301-496-6035 Email:  jettd@ninds.nih.gov nbsp;

Notice of Correction to Key Dates in RFA-NS-18-029 "BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trial Not Allowed)

NOT
Wednesday, May 23, 2018
Friday, January 1, 2021
NOT-NS-18-070

Funding Opportunity Purpose

Notice Correction Key Dates RFA-NS-18-029 BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP U01 Clinical Trial Allowed) Notice Number: NOT-NS-18-070 Key Dates Release Date: 23, 2018 Related Announcements RFA-NS-18-029 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to inform interested applicants a correction the Key Dates RFA-NS-18-029 BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP U01 Clinical Trial Allowed)".  Specifically, Advisory Council Review dates January 2019 and January 2020 and Earliest Start Dates February 2019 and February 2020. Part 1. Overview Information Key Dates Currently Reads: Advisory Council Review January 2019 Earliest Start Date February 2019 Modified Read: Advisory Council Review January 2019 and January 2020 Earliest Start Date February 2019 and February 2020 other aspects this FOA remain same. Inquiries Please direct inquiries to: James Gnadt, PhD  National Institute Neurological Disorders Stroke NINDS)  Telephone: 301-496-9964  Email: BRAINCircuits@nih.gov

Notice of Support for Administrative Supplements to Embed Ethicists into BRAIN Initiative Supported Research

NOT
Tuesday, May 1, 2018
Friday, January 1, 2021
NOT-MH-18-034

Funding Opportunity Purpose

Notice Support Administrative Supplements Embed Ethicists BRAIN Initiative Supported Research Notice Number: NOT-MH-18-034 Key Dates Release Date: 01, 2018 Related Announcements None Issued National Institute Mental Health NIMH) National Eye Institute NEI) National Institute Aging NIA) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Drug Abuse NIDA) National Institute Neurological Disorders Stroke NINDS) National Center Complementary Integrative Health NCCIH) Purpose Brain Research through Advancing Innovative Neurotechnologies BRAIN) Initiative aimed revolutionizing neuroscience through development application innovative technologies map neural circuits, monitor modulate activity, understand they contribute thoughts, sensations, emotions behavior. NIH issued variety Funding Opportunity Announcements FOAs) will support projects apply technologies understand neural circuit function the context specific circuits, resulting a diverse portfolio research the fundamental biology nervous system function.  purpose this announcement to notify research community NIH encouraging applications to PA-18-591 to integrate neuroethics perspectives approaches existing BRAIN Initiative awards. Supplement applications encouraged ongoing BRAIN Initiative projects can readily incorporate core ethical issues associated research focused the human brain resulting emerging technologies advancements research development supported the BRAIN Initiative. intent that efforts supported through administrative supplement be both complimentary integrative the transformative, breakthrough neuroscience discoveries supported through BRAIN Initiative.   an administrative supplement, work proposed needs be within scope the research is already supported. Research proposed supplement applications should clear relevance the BRAIN Initiative. proposed work cover pilot projects, resource development, personnel costs embedding neuroethics the research project. each case, work proposed should feasible complete within one-year timeframe with limited funds permitted. should also show promise becoming more substantial project might attract additional funding. Investigators should submit applications responses the parent active administrative supplement announcement https://grants.nih.gov/grants/guide/pa-files/PA-18-591.html) using electronic submission. Electronic applications strongly encouraged.. Individual requests be more 100,000 direct costs exclusive Facilities Administrative costs sub-contracts may for year only. Requests must received June 15 funding FY 2018. Inquiries Please direct inquiries to: James Churchill National Institute Mental Health NIMH) Telephone: 301-443-3621 Email: churchillj@mail.nih.gov 

NINDS Announces Modifications to Special Council Review Policy

NOT
Friday, April 27, 2018
Friday, January 1, 2021
NOT-NS-18-060

Funding Opportunity Purpose

NINDS Announces Modifications Special Council Review Policy Notice Number: NOT-NS-18-060 Key Dates Release Date: April 27, 2018 Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) Purpose Notice announces modifications the Special Council Review SCR) policy, pertains well-funded Program Director(s)/Principal Investigator(s) PD(s)/PI(s)] submitting applications NINDS.  new policy: 1) lowers funding threshold requires special review a pending application the National Advisory Neurological Disorders Stroke NANDS) Council and; 2) sets more stringent payline pending applications cause PD/PI exceed threshold. Background September 2012, NIH implemented SCR policy, whereby Advisory Councils instructed provide additional scrutiny new renewal applications investigators already receiving 1.0M more direct cost NIH Research Project Grant RPG) funding.  2012 NIH policy recognized institute-specific variations the general policy be developed consultation individual Councils.   NANDS Council discussed NIH policy its September 2017 February 2018 meetings, approved modified policy described here.  goals this policy are: 1) permit Institute fund larger, diverse pool researchers 2) ensure PIs sufficient bandwidth oversee rigorous research effective mentorship their laboratories.   Policy Effective applications under funding consideration the January 2019 meeting the NANDS Council, NINDS refine Special Council Review policy procedures support research well-funded investigators.  Under new policy, well-funded investigator defined an individual NIH research support exceeding 1M direct costs the time the Council meeting, including pending application.  the purposes this policy, only research support which investigator the PI Co-PI be considered.  competing applications well-funded investigators primary assignment NINDS exceptions noted below) be subject a percentile payline is ½ the NINDS payline the Council round question https://www.ninds.nih.gov/Funding/About-Funding/NINDS-Funding-Strategy; the payline an odd number, SCR payline be rounded down the next integer. questions applications are percentiled, applicants should contact individual noted below further information.  Exceptions this policy be rare, will determined after review NINDS staff, NANDS Council, NINDS leadership. contrast the existing SCR policy, competing applications P01s, Centers, other Multi-Component RPGs be included this policy.  Multi-PD/PI projects also subject the policy one more the PD/PIs NIH research support exceeding 1.0M inclusive the pending application.  Applications will excluded this policy include those intended support training, conferences, core facilities, research resources.  Applications submitted response SBIR/STTR solicitations to small number specially designated Funding Opportunity Announcements also excluded. identifying well-funded investigators, active NIH research support be considered except awards support training, conferences, core facilities, research resources, SBIR/STTR activities.  individual PD/PI’s financial allocation Multi-PD/PI multi-component projects be used determine individual’s level support. Grants are a no-cost extension single year competitive administrative supplements not included this determination. Factors may contribute a funding recommendation beyond SCR payline include conducting types research are inherently costly, PD/PI’s available bandwidth commit time effort commensurate the application’s complexity scope, the type, source end dates the PD/PI’s NIH support.  PDs/PIs be permitted temporarily exceed 1M threshold a period no than 90 days ensure continuity funding support. PDs/PIs also discontinue previously funded grants begin work the new project. Please visit NINDS website additional details a list Frequently Asked Questions. NINDS recognizes this policy change research plans some laboratories, the intent to advance mission the Institute supporting larger, diverse group investigators. Inquiries Please direct inquiries to: Anna Taylor, Ph.D. National Institute Neurological Disorders Stroke Telephone: 301-827-3565 Email: taylorann@mail.nih.gov

Notice of Availability of Administrative Supplements for Secondary Analysis of Existing Datasets within the Rare Diseases Clinical Research Network (RDCRN) to Explore Outcomes Relevant to Rare Diseases

NOT
Wednesday, April 25, 2018
Friday, January 1, 2021
NOT-TR-18-019

Funding Opportunity Purpose

Notice Availability Administrative Supplements Secondary Analysis Existing Datasets within Rare Diseases Clinical Research Network RDCRN) Explore Outcomes Relevant Rare Diseases Notice Number: NOT-TR-18-019 Key Dates Release Date: April 25, 2018 Related Announcements PA-18-591 Issued National Center Advancing Translational Sciences NCATS) National Heart, Lung, Blood Institute NHLBI) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Neurological Disorders Stroke NINDS) Purpose National Center Advancing Translational Science NCATS) announces opportunity investigators relevant active Rare Diseases Clinical Research Consortia RDCRC) Rare Diseases Clinical Research Network RDCRN) U54) submit administrative supplement requests the NIH Parent Funding Opportunity Announcement FOA), ldquo;Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional)” PA-18-591 .   is vitally important begin use existing RDCRC datasets they intended: through secondary analyses develop new hypotheses Rare Diseases outcomes; such identify particular vulnerabilities specific populations; explore age, sex racial differences may warrant larger studies; discover new treatment/rehabilitation approaches; reveal correlations among outcomes outcome domains can guide future studies.   goal to existing human datasets well-focused secondary analyses investigate novel scientific ideas new models, systems, tools, methods, technologies have potential significant impact biomedical biobehavioral research areas relevant the RDCRN’s mission. RDCRN's mission to foster development scientific knowledge needed enhance health, productivity, independence, quality-of-life individuals Rare Diseases. Program Director(s)/Principal Investigators PIs) strongly encouraged partner Early Stage Investigators ESIs).  Projects must propose collect new data must within scope the current award. Budget Available Funds Budgets limited no than 50K direct costs. Award Project Period Supplement project budget periods limited the remaining FY18 budget period.  be eligible, parent award must active i.e. be an extension period), the research proposed the supplement must accomplished within remaining active budget period started FY18 the existing parent award. earliest anticipated start date July 1, 2018. Review process Administrative Review be conducted a committee NIH RDCRN Program Officers/Program Directors final decisions by funding ICs Page Limit NCATS consider supplements a Research Strategy no than 3 pages. Submitting Application Applicants should begin application stating: ldquo;This application being submitted response NOT-TR-18-019".  additional information, the parent program announcement Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) PA-18-591. Applications these administrative supplements due 5:00 PM local time June 8, 2018. Inquiries Please direct inquiries to: Tiina K. Urv, PhD National Center the Advancement Translational Science NCATS) Telephone: 301-827-2746 Email: urvtiina@nih.gov

Notice to Extend the Expiration Date and Change Receipt Dates for PAR-16-458 "NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32)"

NOT
Monday, April 23, 2018
Friday, January 1, 2021
NOT-NS-18-061

Funding Opportunity Purpose

Notice Extend Expiration Date Change Receipt Dates PAR-16-458 NINDS Ruth L. Kirschstein National Research Service Award NRSA) Training Postdoctoral Fellows F32)" Notice Number: NOT-NS-18-061 Key Dates Release Date: April 23, 2018 Related Announcements PAR-16-458 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants there be change receipt dates for Funding Opportunity Announcement FOA) PAR-16-458 NINDS Ruth L. Kirschstein National Research Service Award NRSA) Training Postdoctoral Fellows F32)" the expiration date be extended one receipt cycle.  Specifically, receipt dates requests submitted under FOA, PAR-16-458 change August 8, 2018, December 8, 2018, April 8, 2019, August 8, 2019 to June 20, 2018, October 18, 2018, February 15, 2019, and June 19, 2019and additional application due date, October 17, 2019, been added this FOA.  new expiration date this FOA is January 8, 2020. Part 1. Overview Information Key Dates Currently Reads: Application Due Date(s) Standard dates  apply (December 8, 2016, April 8, 2017, August 8, 2017, December 8, 2017, April 8, 2018, August 8, 2018, December 8, 2018, April 8, 2019, August 8, 2019) 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Expiration Date September 8, 2019 Modified Read: Application Due Date(s) December 8, 2016, April 8, 2017, August 8, 2017, December 8, 2017, April 8, 2018, June 20, 2018, October 18, 2018, February 15, 2019, June 19, 2019, and October 17, 2019 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Expiration Date January 8, 2020 other aspects this FOA remain same. Inquiries Please direct inquiries to: Stephen Korn, Ph.D. National Institute Neurological Disorders Stroke Telephone: 301-496-188 Email: korns@mail.nih.gov

Notice of Change of NINDS K99/R00 Eligibility Timeframe for Parents Who Have a Child during the Standard K99/R00 Application Eligibility Window

NOT
Tuesday, April 17, 2018
Friday, January 1, 2021
NOT-NS-18-055

Funding Opportunity Purpose

RESCINDED - Notice Change NINDS K99/R00 Eligibility Timeframe Parents Have Child during Standard K99/R00 Application Eligibility Window Notice Number: NOT-NS-18-055 Key Dates Release Date: April 17, 2018 Related Announcements NOT-NS-18-042 - RESCINDED Issued National Institute Neurological Disorders Stroke NINDS) Purpose notice being issued inform recipients NIH rescinded NOT-NS-18-042 Notice Change NINDS K99/R00 Eligibility Timeframe Parents Have Child during Standard K99/R00 Application Eligibility Window" until further review the policy. Inquiries Please direct inquiries to: Stephen Korn, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-4188 Email: korns@ninds.nih.gov

Notice of Change of Receipt Dates for PA-17-442 "Administrative Supplement for the NINDS Research Education Program for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supplement)"

NOT
Friday, April 13, 2018
Friday, January 1, 2021
NOT-NS-18-059

Funding Opportunity Purpose

Notice Change Receipt Dates PA-17-442 Administrative Supplement the NINDS Research Education Program Residents Fellows Neurology, Neurosurgery, Neuropathology, Neuroradiology Emergency Medicine Admin Supplement)" Notice Number: NOT-NS-18-059 Key Dates Release Date: April 13, 2018 Related Announcements PA-17-442 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to inform potential applicants there be change receipt dates PA-17-442 Administrative Supplements the NINDS Research Education Program Residents Fellows Neurology, Neurosurgery, Neuropathology, Neuroradiology Emergency Medicine R25)". Currently, administrative supplement requests support residents fellows start participation July a given year due October 31 the prior year. Effective immediately, this notice, receipt date these administrative supplement requests be changed October 15 the year prior the July start date intended participation.   Specifically, receipt dates requests submitted under FOA, PA-17-442 change October 31, 2018 October 31, 2019 to October 15, 2018 and October 15, 2019. Part 1. Overview Information Key Dates Currently Reads: Application Due Date(s) October 31, 2017, October 31, 2018, October 31, 2019 5:00 PM local time applicant organization.Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Expiration Date November 1, 2019   Modified Read:   Application Due Date(s) October 31, 2017, October 15, 2018, and October 15, 2019 by 5:00 PM local time applicant organization. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Expiration Date October 16, 2019   other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Stephen Korn, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-4188 Email: korns@mail.nih.gov

Alzheimers Disease and its related Dementias (AD/ADRD)-focused Administrative supplements for NIH grants that are not focused on Alzheimers disease.

NOT
Thursday, April 12, 2018
Friday, January 1, 2021
NOT-AG-18-008

Funding Opportunity Purpose

Alzheimer's Disease its related Dementias AD/ADRD)-focused Administrative supplements NIH grants are focused Alzheimer's disease Notice Number: NOT-AG-18-008 Key Dates Release Date: April 12, 2018 Related Announcements NOT-AI-18-032 NOT-HD-18-010 PA-18-591 Issued National Institute Aging NIA) National Cancer Institute NCI) National Eye Institute NEI) National Heart, Lung, Blood Institute NHLBI) National Human Genome Research Institute NHGRI) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) National Institute Dental Craniofacial Research NIDCR) National Institute Deafness Other Communication Disorders NIDCD) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute General Medical Sciences NIGMS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Institute Minority Health Health Disparities NIMHD) National Library Medicine NLM) Fogarty International Center FIC) National Center Complementary Integrative Health NCCIH) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Office Research Women’s Health ORWH) Office Strategic Coordination Common Fund) Purpose participating Institutes Centers ICs) inviting applications expand existing awards these ICs are currently focused Alzheimer’s disease AD) its related dementias ADRD) allow to develop focus AD/ADRD. Active awards project end dates FY 2019 later eligible. award not in terminal cost extension going no cost extension FY2018. administrative supplements work proposed needs be within scope the research training is already supported. Center awards resource awards most likely be able justify supplements they tend have broad content scope. research grants also qualify the current research on related topic such cognitive decline aging, caregiving, health disparities). possible topics include research the biology neurodegeneration, genetics, imaging, on pain perception communication. Topics also include possible connections existing conditions are being studied: such links cardiovascular other diseases, common pathways degeneration, sex gender influences incidence, on previously unidentified risk factors. Also work focuses advances methodology, machine learning other modeling, or on biostatistical tools have application research Alzheimer’s its related dementias be appropriate. NIA developed website shows abstracts Reporter) a sample awards are recognized pursuing AD/ADRD research under current guidelines. site also includes description the categories research NIH currently identifies Alzheimer's disease Alzheimer's disease-related dementias. part the application investigators should submit abstract the proposed research shows relevance AD/ADRD. work include pilot projects, resource development. Investigators should submit applications responses the parent active administrative supplement PA: https://grants.nih.gov/grants/guide/pa-files/PA-18-591.html Individual requests be more 250,000 direct costs exclusive Facilities Administrative costs sub-contracts except the information NHGRI below). Requests be one year support only.  Though supplement requests not limited one per parent grant, will consider substantial additional funding an award beyond scope. Also, before submitting supplement request, principal investigators strongly encouraged contact program officers the Institute, Center Office supporting award discuss whether proposed supplement within scope. Requests must received June 8 funding FY 2018. Institute, Center Office-specific Instructions National Human Genome Research Institute: NHGRI collaboration NIA support supplements NHGRI grants to 500,000 direct cost, support research accomplishes NIA’s research goals described this notice. NHGRI support studies provide generalizable methods knowledge all three scientific areas genome sciences, genomic medicine genomics society. Work proposed supplements must fall within scope the aims the NHGRI grant be supplemented. Investigators encouraged contact NHGRI Scientific Program Officer the grant be supplemented before preparing application, discuss relevance the proposed research the parent grant to Institute's research priorities. National Institute General Medical Sciences: NIGMS’s MIRA program provides support an investigator's overall program research within Institute’s mission, MIRA awardees not eligible this supplement program. Office Strategic Coordination:  Common fund awardees are interested applying should contact Dr. Ravi Basavappa the Office Strategic Coordination Common Fund) before applying. Review process IC conduct administrative reviews applications their IC separately. NIA make funds available up ten awards each the participating ICs is allocating to 20 million this cross-IC program. IC conduct administrative reviews applications their IC separately. NIA make funds available up ten awards each the participating ICs is allocating to 20 million this cross-IC program.   Criteria: 1.      the work proposed within scope the active award? 2.      the work proposed focused Alzheimer’s disease its related dementias? 3.      the work likely stimulate additional activity leading progress AD/ADRD? Inquiries Please direct inquiries to: Robin A. Barr National Institute Aging NIA) Telephone: 301-402-7715 E-mail: BarrR@mail.nih.gov Crystal Wolfrey National Cancer Institute NCI) Telephone: 240-276-6277 E-mail: wolfreyc@mail.nih.gov Martha Flanders National Eye Institute NEI) Telephone: 301-451-2020 E-mail: Martha.flanders@nih.gov Jue Chen, Ph.D. National Heart, Lung, Blood Institute NHLBI) Telephone: 301-435-0550 Email: jue.chen@nih.gov Bettie Graham National Human Genome Research Institute NHGRI) Telephone: 301-496-7531 E-mail: grahambj@exchange.nih.gov Abraham Bautista National Institute Alcohol Abuse Alcoholism NIAAA) Telephone: 301-443-9737 E-mail: Bautista@mail.nih.gov Michael Minnicozzi, Ph.D. National Institute Allergy Infectious Diseases NIAID) Telephone: 240-627-3532 Email: minnicozzim@niaid.nih.gov Melinda Nelson National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Telephone: 301-435-5278 E-mail: nelsonm@exchange.nih.gov Randy King National Institute Biomedical Imaging Bioengineering NIBIB) Telephone:301-451-4780 E-mail: randy.king@nih.gov Judith Cooper National Institute Deafness Other Communication Disorders NIDCD) Telephone: 301-496-5061 E-mail: cooperj@nidcd.nih.gov Preethi Chander National Institute Dental Craniofacial Research NIDCR) Telephone: 301-827-4620 E-mail: Preethi.chander@nih.gov Luke Stoekel National Institute Diabetes Digestive Kidney Diseases NIDDK) Telephone: 301-741-9223 E-mail: luke.stoeckel@nih.gov Kevin Walton National Institute Drug Abuse NIDA) Telephone: 301-827-5980 kevin.walton@nih.gov Jonathan Hollander National Institute Environmental Health Sciences NIEHS) Telephone: 984-287-3269 E-mail: jonathan.hollander@nih.gov Janna Wehrle National Institute General Medical Sciences NIGMS) Telephone: 301451-6446 E-mail: wehrlej@nigms.nih.gov Jovier Evans National Institute Mental Health NIMH) Telephone: 301-443-1369 E-mail: jevans1@mail.nih.gov Roderick Corriveau National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-5680 E-mail: roderick.corriveau@nih.gov Lois Tully National Institute Nursing Research NINR) Telephone: 301-594-5968 E-mail: lois.tully@nih.gov Adelaida Rosario National Institute Minority Health Health Disparities NIMHD) Telephone: 301-402-1366 E-mail: Adelaida.rosario@nih.gov Hua-Chuan Sim National Library Medicine NLM) Telephone: 301-594-4882 E-mail: simh@mail.nlm.nih.gov Marya Levintova Fogarty International Center FIC) Telephone: 301-496-1653 E-mail: levintovam@mail.nih.gov Dave Clark National Center Complementary Integrative Health NCCIH) Telephone: 301-827-1916 E-mail: dave.clark@nih.gov Stephanie Murphy Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Telephone: 301-435-0744 E-mail: Stephanie.murphy@nih.gov Chyren Hunter Office Research Women’s Health ORWH) Telephone: 301-402-1770 Email: hunterc@mail.nih.gov Ravi Basavappa Office Strategic Coordination OSC) Telephone: 301-435-7204 E-mail: ravikumar.basavappa@nih.gov

Notice of NINDS Policy for Submission of Applications Containing Clinical Trials

NOT
Tuesday, April 3, 2018
Friday, January 1, 2021
NOT-NS-18-054

Funding Opportunity Purpose

Notice NINDS Policy Submission Applications Containing Clinical Trials Notice Number: NOT-NS-18-054 Key Dates Release Date: April 3, 2018 Related Announcements NOT-NS-16-034 RESCINDED NOT-NS-18-011  Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to clarify policy submitting investigator-initiated clinical trial applications NINDS. Unless otherwise indicated NIH NINDS Funding Opportunity Announcements FOAs), clinical trials designed answer specific questions the safety, tolerability, efficacy, effectiveness, clinical management, and/or implementation pharmacologic, behavioral, biologic, surgical, device invasive non-invasive) interventions only supported NINDS submitted an NINDS clinical trials-specific FOA.  current list active NINDS clinical trials FOAs available at https://www.ninds.nih.gov/Current-Research/Research-Funded-NINDS/Clinical-Research.   Applicants strongly advised consult NINDS program staff prior submitting clinical trial application determine appropriate funding opportunity announcement. Inquiries Please direct inquiries to: Peter Gilbert, Sc.M. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-0870 Email: GilbertP@ninds.nih.gov nbsp;

Pages